Crinetics Pharmaceuticals, Inc. (CRNX) SEC Filings — 2024
39 SEC filings for Crinetics Pharmaceuticals, Inc. (CRNX) in 2024.
Filings
- Crinetics Pharmaceuticals Announces Director Departure, New CMO — 8-K · Dec 16, 2024
- Crinetics Pharmaceuticals Files 8-K — 8-K · Dec 9, 2024
- Crinetics Pharmaceuticals, Inc. SC 13G Filing — SC 13G · Nov 14, 2024
- Crinetics Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Crinetics Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Crinetics Pharmaceuticals Files Q3 2024 10-Q — 10-Q · Nov 12, 2024
- Crinetics Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
- Crinetics Pharmaceuticals, Inc. SC 13G Filing — SC 13G · Nov 8, 2024
- Crinetics Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Nov 4, 2024
- Crinetics Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Oct 17, 2024
- Crinetics Pharmaceuticals Appoints New CMO and CSO — 8-K · Oct 16, 2024
- Crinetics Pharmaceuticals Files 8-K — 8-K · Oct 9, 2024
- Crinetics Pharmaceuticals Files 8-K — 8-K · Sep 26, 2024
- Crinetics Pharmaceuticals Announces Executive and Board Changes — 8-K · Sep 17, 2024
- Crinetics Pharmaceuticals Files Q2 2024 10-Q — 10-Q · Aug 8, 2024
- Crinetics Pharmaceuticals Files 8-K — 8-K · Jun 21, 2024
- Crinetics Pharmaceuticals Files 8-K on Shareholder Votes — 8-K · Jun 10, 2024
- Crinetics Pharmaceuticals Files 8-K — 8-K · Jun 3, 2024
- Crinetics Pharmaceuticals Files 8-K — 8-K · May 22, 2024
- Crinetics Pharmaceuticals, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
- Crinetics Pharmaceuticals Files 8-K for Regulation FD — 8-K · May 8, 2024
- Crinetics Pharmaceuticals, Inc. Files DEF 14A with Executive Compensation Details — DEF 14A · Apr 25, 2024
- Crinetics Pharmaceuticals, Inc. 8-K Filing — 8-K · Apr 4, 2024
- Crinetics Pharmaceuticals Appoints New Chief Medical Officer — 8-K · Mar 19, 2024
- Novartis to Acquire Crinetics Pharmaceuticals for $2.7B — 8-K · Mar 12, 2024
- Crinetics Pharmaceuticals, Inc. SC 13G Filing — SC 13G · Mar 11, 2024
- Crinetics Pharmaceuticals Files 8-K — 8-K · Mar 1, 2024
- Crinetics Pharmaceuticals, Inc. Files 2023 Annual Report (10-K) — 10-K · Feb 28, 2024
- Crinetics Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Crinetics Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Crinetics Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Crinetics Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Crinetics Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Crinetics Pharmaceuticals, Inc. SC 13G Filing — SC 13G · Feb 13, 2024
- FMR LLC Discloses 6.053% Passive Stake in Crinetics Pharma — SC 13G · Feb 9, 2024
- Wellington Management Amends Crinetics Pharma Stake — SC 13G/A · Feb 8, 2024
- BlackRock Maintains Significant Stake in Crinetics Pharma — SC 13G/A · Jan 25, 2024
- State Street Corp. Discloses Passive Stake in Crinetics Pharma — SC 13G · Jan 24, 2024
- Crinetics Pharma Files 8-K, Confirms Nasdaq Listing — 8-K · Jan 8, 2024